Special Offers & Instant Savings for Members | Cornerstones4Care®

Offers

With Cornerstones4Care®, you can take advantage of free personalized support, tips, tools, and online resources to help manage your diabetes. Eligible patients may also be able to access the following:

Instant Savings Card

Register and activate your Instant Savings Card if you are interested in:

Pharmacy discount card 
  • Saving on prescription refills for up to 2 years, if eligiblea
  • Automatic enrollment in the Cornerstones4Care® patient support program, including access to the online Diabetes Health Coach
  • A FREE box of Novo Nordisk needles, if eligiblea

aEligibility and other restrictions apply. See below for complete details.

Novo Nordisk Instant Savings Card

Details of Offer, Including Restrictions on Eligibility and Other Limitations

You are not eligible for this savings offer if you are enrolled in or participate in Medicaid, Medicare, Medigap, VA, DOD, TRICARE, or any similar federal or state health care program (each a Government Program), or where prohibited by state law. The Federal Employees Health Benefits (FEHB) Program is not a Government Program for the purposes of this savings program. You must not submit, or have submitted on your behalf by a pharmacist or other third party, a claim for reimbursement or coverage to any Government Program for items purchased with this savings card.

Program terms and conditions:

  • Pay as little as $25 when you start on a Novo Nordisk product, and as little as $20 for the next prescribed product and each refill for up to 2 years. Novo Nordisk will pay up to $100 of your co-pay for each of your first 24 prescription fills for 2 years from the time of initial card activation. Eligibility and other restrictions apply. Novo Nordisk reserves the right to modify or cancel this program at any time. If your co-pay is already $25 or less for your first prescribed Novo Nordisk product or $20 or less for your next prescribed Novo Nordisk product, this offer does not apply
  • Get 1 free box of Novo Nordisk needles when you activate your Savings Card and enroll in the program. Maximum savings of $60. Limit 1 box of needles per person. Needles are sold separately and may require a prescription in some states. Needles must not be shared
  • Offer good only in the USA, Puerto Rico, Guam, Saipan and Virgin Islands at participating retail pharmacies and cannot be redeemed at government-subsidized clinics. Void where taxed, restricted, or prohibited by law
  • Absent a change in Massachusetts law, effective July 1, 2019, the Savings Card will no longer be valid for residents of Massachusetts
  • Patients must be enrolled in a commercial insurance plan. Offer excludes full cash-paying patients
  • Patient is responsible for complying with any insurance carrier co-payment disclosure requirements, including disclosing any savings received from this program
  • Re-confirmation of information may be requested periodically to ensure accuracy of data and compliance with terms
  • Patient must be 18 years of age or older to redeem the Savings Card
  • Participating patients must re-present their Novo Nordisk Instant Savings Card if changing pharmacies
  • This offer is limited to 1 card per patient. This card is not transferable
  • The Novo Nordisk Instant Savings Card may be used for mail order
  • Participating pharmacists must comply with all applicable laws and contractual or other obligations as a pharmacy provider 
  • Participating patients and pharmacists understand and agree to comply with the terms and conditions of this offer as set forth herein
  • This savings program cannot be combined with any other coupon, certificate, voucher, or similar offer
  • This is not an insurance program

Tresiba® Instant Savings Card

You are not eligible for this savings offer if you are enrolled in or participate in Medicaid, Medicare, Medigap, VA, DOD, TRICARE, or any similar federal or state health care program (each a Government Program), or where prohibited by state law. For purposes of this savings program, the Federal Employee Health Benefits Program (FEHBP) is not a federal or state government health care program. You must not submit, or have submitted on your behalf by a pharmacist or other third party, a claim for reimbursement or coverage to any Government Program for items purchased with this savings card.

Program terms and conditions:

  • Pay as little as $15 out of pocket. Novo Nordisk will pay up to $500 of your co-pay for each of your first 24 prescription fills for 2 years from the time of initial card activation. Eligibility and other restrictions apply. Novo Nordisk reserves the right to modify or cancel this program at any time. If your co-pay is already $15 or less, this offer does not apply
  • Get 1 free box of Novo Nordisk needles when you activate your Savings Card and enroll in the program. Limit 1 box of needles per person. Needles are sold separately and may require a prescription in some states. Needles must not be shared
  • Offer good only in the USA, Puerto Rico, Guam, Saipan and Virgin Islands at participating retail pharmacies and cannot be redeemed at government-subsidized clinics. Void where taxed, restricted, or prohibited by law
  • Absent a change in Massachusetts law, effective July 1, 2019, the Savings Card will no longer be valid for residents of Massachusetts
  • Patients must be enrolled in a commercial insurance plan. Offer excludes full cash-paying patients
  • Patient is responsible for complying with any insurance carrier co-payment disclosure requirements, including disclosing any savings received from this program
  • Re-confirmation of information may be requested periodically to ensure accuracy of data and compliance with terms
  • Patient must be 18 years of age or older to redeem the Savings Card
  • Participating patients must re-present their Tresiba® Instant Savings Card if changing pharmacies
  • This offer is limited to 1 card per patient. This card is not transferable
  • The Tresiba® Instant Savings Card may be used for mail order
  • Participating pharmacists must comply with all applicable laws and contractual or other obligations as a pharmacy provider
  • Participating patients and pharmacists understand and agree to comply with the terms and conditions of this offer as set forth herein
  • This savings program cannot be combined with any other coupon, certificate, voucher, or similar offer
  • This is not an insurance program

Xultophy® 100/3.6 Savings Card

Details of Offer, Including Restrictions on Eligibility and Other Limitations

You are not eligible for this savings offer if you are enrolled in or participate in Medicaid, Medicare, Medigap, VA, DOD, TRICARE, or any similar federal or state health care program (each a Government Program), or where prohibited by state law. For purposes of this savings program, the Federal Employee Health Benefits Program (FEHBP) is not a federal or state government health care program. You must not submit, or have submitted on your behalf by a pharmacist or other third party, a claim for reimbursement or coverage to any Government Program for items purchased with this savings card.

Program terms and conditions:

  • Pay as little as $30 out of pocket. Novo Nordisk will pay up to $400 of your co-pay for each of your first 12 prescription fills for 1 year from the time of initial card activation. Eligibility and other restrictions apply. Novo Nordisk reserves the right to modify or cancel this program at any time. If your co-pay is already $30 or less, this offer does not apply
  • Get 1 free box of Novo Nordisk needles when you activate your Savings Card and enroll in the program. Limit 1 box of needles per person. Needles are sold separately and may require a prescription in some states. Needles must not be shared
  • Offer good only in the USA, Puerto Rico, Guam, Saipan and Virgin Islands at participating retail pharmacies and cannot be redeemed at government-subsidized clinics. Void where taxed, restricted, or prohibited by law
  • Absent a change in Massachusetts law, effective July 1, 2019, the Savings Card will no longer be valid for residents of Massachusetts
  • Patients must be enrolled in a commercial insurance plan. Offer excludes full cash-paying patients
  • Patient is responsible for complying with any insurance carrier co-payment disclosure requirements, including disclosing any savings received from this program
  • Re-confirmation of information may be requested periodically to ensure accuracy of data and compliance with terms
  • Patient must be 18 years of age or older to redeem the Savings Card
  • Participating patients must re-present their Xultophy® 100/3.6 Savings Card if changing pharmacies
  • This offer is limited to 1 card per patient. This card is not transferable
  • The Xultophy® 100/3.6 Savings Card may be used for mail order
  • Participating pharmacists must comply with all applicable laws and contractual or other obligations as a pharmacy provider
  • Participating patients and pharmacists understand and agree to comply with the terms and conditions of this offer as set forth herein
  • This savings program cannot be combined with any other coupon, certificate, voucher, or similar offer
  • This is not an insurance program

Indication and Usage for Victoza® (liraglutide) injection 1.2 mg or 1.8 mg

What is Victoza®?

Victoza® is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes, and should be used along with diet and exercise.

  • Victoza® is not recommended as the first choice of medicine for treating diabetes.
  • It is not known if Victoza® can be used in people who have had pancreatitis.
  • Victoza® is not a substitute for insulin and is not for use in people with type 1 diabetes or people with diabetic ketoacidosis.
  • It is not known if Victoza® can be used with mealtime insulin.
  • It is not known if Victoza® is safe and effective for use in children.

 

Important Safety Information for Victoza®

What is the most important information I should know about Victoza®?
Victoza® may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Victoza® and medicines that work like Victoza® caused thyroid tumors, including thyroid cancer. It is not known if Victoza® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

Who should not use Victoza®?
Do not use Victoza® if:

  • you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • you are allergic to liraglutide or any of the ingredients in Victoza®.

What should I tell my health care provider before using Victoza®?
Before using Victoza®, tell your health care provider if you:

  • have or have had problems with your pancreas, kidneys, or liver.
  • have any other medical conditions or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.
  • are pregnant or breastfeeding or plan to become pregnant or breastfeed. 

Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.

How should I use Victoza®?

  • Do not mix insulin and Victoza® together in the same injection.
  • You may give an injection of Victoza® and insulin in the same body area (such as your stomach area), but not right next to each other.
  • Do not share your Victoza® pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

What are the possible side effects of Victoza®?
Victoza® may cause serious side effects, including:

  • inflammation of your pancreas (pancreatitis). Stop using Victoza® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
  • low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Victoza® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery.
  • kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse.
  • serious allergic reactions. Stop using Victoza® and get medical help right away if you have any symptoms of a serious allergic reaction, including itching, rash, or difficulty breathing.

The most common side effects of Victoza® may include headache, nausea, diarrhea, vomiting, and anti-liraglutide antibodies in your blood.

See Victoza® Prescribing Information.

 

What is XULTOPHY® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL?

Xultophy® 100/3.6 is an injectable prescription medicine that contains 2 diabetes medicines, insulin degludec, 100 units/mL, and liraglutide, 3.6 mg/mL. Xultophy® 100/3.6 should be used along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes mellitus when blood sugar levels are not well controlled on: 1) basal insulin (less than 50 units daily) or 2) liraglutide (less than or equal to 1.8 mg daily).

  • Xultophy® 100/3.6 is not recommended as the first choice of medicine for treating diabetes.
  • It is not known if Xultophy® 100/3.6 can be used in people who have had pancreatitis.
  • Xultophy® 100/3.6 is not recommended for use in combination with any other product containing liraglutide or another GLP-1 receptor agonist.
  • Xultophy® 100/3.6 is not for use in people with type 1 diabetes or people with diabetic ketoacidosis (increased ketones in the blood or urine).
  • It is not known if Xultophy® 100/3.6 can be used with mealtime insulin.
  • It is not known if Xultophy® 100/3.6 is safe and effective for use in children under 18 years of age.

Important Safety Information for Xultophy® 100/3.6

What is the most important information I should know about Xultophy® 100/3.6?

Xultophy® 100/3.6 may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, liraglutide, one of the components of Xultophy® 100/3.6, and medicines that work like liraglutide caused thyroid tumors, including thyroid cancer. It is not known if Xultophy® 100/3.6 will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

Who should not use Xultophy® 100/3.6? Do not use Xultophy® 100/3.6 if:

  • you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • you are allergic to insulin degludec, liraglutide, or any of the ingredients in Xultophy® 100/3.6.
  • you are having an episode of low blood sugar.

What should I tell my health care provider before using Xultophy® 100/3.6?

Tell your health care provider about all your medical conditions, including if you:

  • have or have had problems with your pancreas, kidneys, or liver.
  • have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.
  • are pregnant or breastfeeding or plan to become pregnant or breastfeed. It is not known if Xultophy® 100/3.6 passes into your breast milk.

Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Before using Xultophy® 100/3.6, talk to your health care provider about low blood sugar and how to manage it.

How should I use Xultophy® 100/3.6?

  • Read the Instructions for Use and take Xultophy® 100/3.6 exactly as your health care provider tells you.
  • Do not change your dosing schedule without first talking to your health care provider.
  • Do not inject Xultophy® 100/3.6 into a muscle or vein.
  • Use Xultophy® 100/3.6 at the same time each day with or without food. Do not take more than 50 units of Xultophy® 100/3.6 each day.
  • Check the Pen label each time you give your injection to make sure you are using the correct medication.
  • Do not share your Xultophy® 100/3.6 pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
  • Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them.

Your dose of Xultophy® 100/3.6 may need to change because of change in level of physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, or other medicines you take.

What should I avoid while taking Xultophy® 100/3.6?

  • Do not drive or operate heavy machinery, until you know how Xultophy® 100/3.6 affects you. Do not drink alcohol or use prescription or over-the-counter medicines that contain alcohol.

What are the possible side effects of Xultophy® 100/3.6?

Xultophy® 100/3.6 may cause serious side effects that can be life-threatening, including:

  • inflammation of your pancreas (pancreatitis). Stop using Xultophy® 100/3.6 and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
  • low blood sugar (hypoglycemia). Signs and symptoms of low blood sugar may include: shakiness, irritability, fast heartbeat, dizziness, weakness, sweating, confusion, drowsiness, hunger, headache and feeling jittery.
  • kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse.
  • serious allergic reactions. Stop using Xultophy® 100/3.6 and get medical help right away, if you have any symptoms of a serious allergic reaction including itching, rash, or difficulty breathing.
  • heart failure in some people if taking diabetes medicines called peroxisome proliferator-activated receptor (PPAR) gamma agonists with insulin containing products like Xultophy® 100/3.6. This can happen even if you have never had heart failure or heart problems. If you already have heart failure, it may get worse while you take PPAR agonists with Xultophy® 100/3.6. Tell your health care provider if you have any new or worse symptoms of heart failure including shortness of breath, tiredness, swelling of your ankles or feet and sudden weight gain.
  • low potassium in your blood (hypokalemia).

The most common side effects of Xultophy® 100/3.6 may include stuffy or runny nose, sore throat, upper respiratory tract infection, increased blood levels of lipase, nausea, diarrhea, and headache.

See Xultophy® 100/3.6 Prescribing Information.

 

What is Tresiba® (insulin degludec injection) 100 U/mL, 200 U/mL?

  • Prescription Tresiba® is a long-acting insulin used to control high blood sugar in adults and children who are 1 year of age and older with diabetes
  • Tresiba® is not for people with diabetic ketoacidosis
  • Tresiba® is not for children who need less than 5 units of Tresiba® each day
  • It is not known if Tresiba® is safe and effective in children under 1 year of age
  • Tresiba® is available in 2 concentrations: 200 units/mL and 100 units/mL

 

Important Safety Information for Tresiba®

Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them. 

Who should not take Tresiba®

Do not take Tresiba® if you: 

  • are having an episode of low blood sugar
  • are allergic to Tresiba® or any of the ingredients in Tresiba®

Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are: 

  • pregnant, planning to become pregnant, or are breastfeeding
  • taking new prescription or over-the-counter medicines, vitamins, or herbal supplements

Talk to your health care provider about low blood sugar and how to manage it. 

How should I take Tresiba®

  • Read the Instructions for Use and take Tresiba® exactly as your health care provider tells you to
  • Do not do any conversion of your dose. The dose counter always shows the selected dose in units
  • Know the type and strength of insulin you take. Do not change the type of insulin you take unless your health care provider tells you to
  • Adults - If you miss or are delayed in taking your dose of Tresiba®:
    • Take your dose as soon as you remember, then continue with your regular dosing schedule
    • Make sure there are at least 8 hours between doses
  • If children miss a dose of Tresiba®:
    • Call the healthcare provider for information and instructions about checking blood sugar levels more often until the next scheduled dose of Tresiba®
  • Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them
  • Do not reuse or share your needles with other people. You may give them a serious infection, or get a serious infection from them
  • Never inject Tresiba® into a vein or muscle
  • Never use a syringe to remove Tresiba® from the FlexTouch® pen

What should I avoid while taking Tresiba®?

  • Do not drive or operate heavy machinery, until you know how Tresiba® affects you
  • Do not drink alcohol or use prescription or over-the-counter medicines that contain alcohol

What are the possible side effects of Tresiba®?

Tresiba® may cause serious side effects that can be life-threatening, including: 

  • Low blood sugar (hypoglycemia). Signs and symptoms that may indicate low blood sugar include anxiety, irritability, mood changes, dizziness, sweating, confusion, and headache
  • Low potassium in your blood (hypokalemia)
  • Heart failure in some people if taken with thiazolidinediones (TZDs). This can happen even if you have never had heart failure or heart problems. If you already have heart failure, it may get worse while you take TZDs with Tresiba®. Tell your health care provider if you have any new or worse symptoms of heart failure including shortness of breath, tiredness, swelling of your ankles or feet, and sudden weight gain 

Your insulin dose may need to change because of change in level of physical activity or exercise, increased stress, change in diet, weight gain or loss, or illness. 

Common side effects may include reactions at the injection site, itching, rash, serious allergic reactions (whole body reactions), skin thickening or pits at the injection site (lipodystrophy), weight gain, and swelling of your hands and feet. 

Get emergency medical help if you have trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.

See Tresiba® Prescribing Information.

 

What is Levemir® (insulin detemir [rDNA origin] injection)?

  • Levemir®  is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.
  • Levemir® is not meant for use to treat diabetic ketoacidosis.

 

Important Safety Information for Levemir®

Do not share your Levemir FlexTouch with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

Who should not take Levemir®

Do not take Levemir® if:

  • you have an allergy to Levemir® or any of the ingredients in Levemir®.

Before taking Levemir®, tell your health care provider about all your medical conditions including, if you are:

  • pregnant, plan to become pregnant, or are breastfeeding.
  • taking new prescription or over-the-counter medicines, including supplements.

Talk to your health care provider about how to manage low blood sugar. 

How should I take Levemir®?

  • Read the Instructions for Use and take exactly as directed.
  • Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to.
  • Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them.
  • Do not reuse or share your needles or syringes with other people. You may give other people a serious infection, or get a serious infection from them.
  • Never inject Levemir® into a vein or muscle.

What should I avoid while taking Levemir®?

  • Do not drive or operate heavy machinery, until you know how it affects you.
  • Do not drink alcohol or use medicines that contain alcohol.

What are the possible side effects of Levemir®

Serious side effects can lead to death, including: 

Low blood sugar. Some signs and symptoms include:

  • anxiety, irritability, mood changes, dizziness, sweating, confusion, and headache.

Your insulin dose may need to change because of:

  • change in level of physical activity, weight gain or loss, increased stress, illness, or change in diet.

Other common side effects may include:

  • reactions at the injection site, itching, rash, serious allergic reactions (whole body reactions), skin thickening or pits at the injection site (lipodystrophy), weight gain, swelling of your hands and feet and if taken with thiazolidinediones (TZDs) possible heart failure.

Get emergency medical help if you have:

  • trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.

See Levemir® Prescribing Information.

 

Indications and Usage for NovoLog® (insulin aspart injection) 100 U/mL

What is NovoLog®?
 
  • NovoLog® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.

 

Important Safety Information for NovoLog®

Do not share your NovoLog® FlexPen®, NovoLog® FlexTouch®, PenFill® cartridge or PenFill® cartridge compatible insulin delivery device with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

Who should not take NovoLog®

Do not take NovoLog® if:

  • your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients. 

Before taking NovoLog®, tell your health care provider about all your medical conditions including, if you are: 

  • pregnant, plan to become pregnant, or are breastfeeding.
  • taking new prescription or over-the-counter medicines, including supplements. 

Talk to your health care provider about how to manage low blood sugar. 

How should I take NovoLog®?

  • Read the Instructions for Use and take exactly as directed.
  • NovoLog® is fast-acting. Eat a meal within 5 to 10 minutes after taking it.
  • Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to.
  • Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them.
  • Do not reuse or share your needles with other people. You may give other people a serious infection, or get a serious infection from them.

What should I avoid while taking NovoLog®?

  • Do not drive or operate heavy machinery, until you know how NovoLog® affects you.
  • Do not drink alcohol or use medicines that contain alcohol.

What are the possible side effects of NovoLog®?

Serious side effects can lead to death, including: 

Low blood sugar. Some signs and symptoms include:

  • anxiety, irritability, mood changes, dizziness, sweating, confusion, and headache.

Your insulin dose may need to change because of:

  • weight gain or loss, increased stress, illness, or change in diet or level of physical activity.

Other common side effects may include:

  • low potassium in your blood, injection site reactions, itching, rash, serious whole body allergic reactions, skin thickening or pits at the injection site, weight gain, and swelling of your hands and feet and if taken with thiazolidinediones (TZDs) possible heart failure.

Get emergency medical help if you have:

  • trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.

See NovoLog® Prescribing Information.

 

Indications and Usage for NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension) 100 U/mL

What is NovoLog® Mix 70/30?
 
  • NovoLog® Mix 70/30 is a man-made insulin used to control high blood sugar in adults with diabetes mellitus.
  • It is not known if NovoLog® Mix 70/30 is safe or effective in children.

Important Safety Information for NovoLog® Mix 70/30

Do not share your NovoLog® Mix 70/30 FlexPen® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.  

Who should not take NovoLog® Mix 70/30?

Do not take NovoLog® Mix 70/30 if:

  • your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

Before taking NovoLog® Mix 70/30, tell your healthcare provider about all your medical conditions including, if you are:

  • pregnant, planning to become pregnant, or are breastfeeding.
  • taking new prescription or over-the-counter medicines, including supplements.

Talk to your health care provider about how to manage low blood sugar.

How should I take NovoLog® Mix 70/30?

  • Read the Instructions for Use and take exactly as directed.
  • NovoLog® Mix 70/30 starts acting fast. If you have type 1 diabetes, inject within 15 minutes before you eat a meal. If you have type 2 diabetes, inject within 15 minutes before or after starting your meal.
  • Do not mix NovoLog® Mix 70/30 with other insulin products or use in an insulin pump.
  • Know the type and strength of your insulin.  Do not change your insulin type unless your health care provider tells you to.
  • Check your blood sugar levels.  Ask your health care provider what your blood sugar levels should be and when you should check them.
  • Do not reuse or share your needles or syringes with other people. You may give other people a serious infection, or get a serious infection from them.

What should I avoid while taking NovoLog® Mix 70/30?

  • Do not drive or operate heavy machinery, until you know how NovoLog® Mix 70/30 affects you.
  • Do not drink alcohol or use medicines that contain alcohol.

What are the possible side effects of NovoLog® Mix 70/30?

Serious side effects can lead to death, including:

Low blood sugar. Some signs and symptoms include:

  • anxiety, irritability, mood changes, dizziness, sweating, confusion, and headache.

Your insulin dose may need to change because of:

  • weight gain or loss, increased stress, illness, or change in diet or level of physical activity.

Other common side effects may include:

  • low potassium in your blood, injection site reactions, itching, rash, serious whole body allergic reactions, skin thickening or pits at the injection site, weight gain, and swelling of your hands and feet and if taken with thiazolidinediones (TZDs), possible heart failure.

Get emergency medical help if you have:

  • trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion. 

See NovoLog® Mix 70/30 Prescribing Information.

 

Have you signed up for the Diabetes Health Coach?

Talk to your health care provider about the importance of diet and exercise in your treatment plan.

Partnership for Prescription Assistance

If you need assistance with prescription drug costs, help may be available.
Visit pparx.org or call 1-888-4PPA-NOW.

Levemir®, Novolin®, NovoLog®, Tresiba®, Victoza®, and Xultophy® are registered trademarks of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.